Your fact-checks will appear here
The Dementia Discovery Fund's investments and their outcomes in terms of peer-reviewed publications
manages a portfolio of companies aimed at discovering disease‑modifying therapeutics for dementia and has backed roughly 19 companies, several of which are pursuing ‑focused programs, but the publicly...
has repeatedly committed large sums to and through direct investments and philanthropy — including a $50M investment in the , a $10M award to the “Part the Cloud” program , substantial commitments to ...
has put money behind brain-focused technologies and research — notably participating in a $75 million Series C round for , a company developing minimally invasive brain‑computer interfaces aimed at re...
The available reporting documents the Dementia Discovery Fund (DDF) as a venture capital vehicle launched in 2015 to finance translational dementia research and lists its backers and fundraising miles...
Declaring a "cure" for dementia—or Alzheimer’s disease specifically—would require far more than a single positive trial result: it would require clear, durable reversal of clinical impairment, concord...
The Gates Foundation does fund work that touches neurodegenerative disease, but it does so indirectly—by supporting institutions and programs whose projects align with broader foundation priorities ra...